Paul E. Ogden, MD, is the new chief executive officer of the Texas A&M Health Science Center (TAMHSC), as well as interim executive vice president of the facility. Dr. Ogden will simultaneously maintain his positions as interim dean for the Texas A&M College of Medicine and interim vice president for clinical affairs.
The announcement was made by Texas A&M University president Michael K. Young following the resignation of former executive vice president and chief executive officer of Texas A&M Health Science Center, Brett Giroir, MD. “Over the past year, under the leadership of Dr. Giroir, the TAMHSC Executive Committee has put in place a comprehensive strategic plan, borne from our individual college aspirations and unifying us all in a common vision of Transforming Health,” stated Ogden in a memo to Texas A&M Health Science Center faculty, staff, and students.
“I look forward to working with each of you to advance those initiatives that are already underway and to continue building upon the strong foundation developed by our faculty, staff and students over the past several years. Thank you for your continued service to Texas A&M and the State of Texas,” added the physician, who graduated from the Texas A&M College of Medicine charter class in 1981.
However, it was not until 2010 that he assumed a full-time leadership position at the TAMHSC College of Medicine, when he was nominated vice dean for academic affairs. Ogden was responsible for a successful multi-year programmatic expansion to double student enrollment, and in July 2013 the American Board of Internal Medicine certified the physician, who is also a fellow of the American College of Physicians.
Ogden has completed an internship in family medicine, a residency in internal medicine at the Mayo Graduate School and a fellowship in Academic Internal Medicine at the University of North Carolina in Chapel Hill.
TAMHSC was led for two years by Giroir, who had already served as the vice chancellor for strategic initiatives at the Texas A&M University System and principal investigator for the Texas A&M Center for Innovation in Advanced Development and Manufacturing. Between 2004 and 2008 he served in the Federal Government as deputy director, then director of the Defense Sciences Office of the Defense Advanced Research Projects Agency (DARPA). Further, he was appointed by Governor Perry last year to serve as director of the Texas Task Force on Infectious Disease Preparedness and Response.